Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 19, 2021
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
Mani Foroohar Maintained (BBIO) at Buy with Decreased Target to $66 on, Nov 19th, 2021
Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $68 to $66 on, Nov 19th, 2021.
Mani has made no other calls on BBIO in the last 4 months.
There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mani
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $88 on, Monday, October 25th, 2021
- Geoff Meacham of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $75 on, Friday, September 10th, 2021
